The FDA has approved an extended-release version of the GLP-1 drug exenatide for older children and teenagers with Type 2 diabetes, Andrew Briskin report for
Insulet has won FDA clearance to market its Omnipod Dash alternate controller-enabled (ACE) infusion pump as an integrated insulin pump. The American company received FDA
With five times the population and ten times the cases of diabetes, what goes on in the US is often of interest, sometimes leading to
BEDFORD, MA–(Marketwire – Dec 14, 2012) – Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology, today announced that the Company has received
Cost is proving a major factor in preventing scientists from finding a cure to diabetes. With more than 27 million diabetics in the U.S. –
